| Literature DB >> 32066563 |
Benjamin Landré1, Rachel Nadif2, Marcel Goldberg3,4, Julie Gourmelen3, Marie Zins3,4, Joël Ankri1,5, Marie Herr1,5.
Abstract
INTRODUCTION: Early management of chronic respiratory diseases (CRDs) and frailty have been identified as key targets towards healthy ageing, but the association between CRDs and frailty has been poorly investigated. We studied the association between asthma and frailty in adults of the GAZEL cohort using different definitions of asthma over the 26 years of follow-up.Entities:
Keywords: asthma; asthma epidemiology
Mesh:
Year: 2020 PMID: 32066563 PMCID: PMC7047496 DOI: 10.1136/bmjresp-2019-000526
Source DB: PubMed Journal: BMJ Open Respir Res ISSN: 2052-4439
Characteristics of the participants in 2015
| All participants (n=12 345) | Participants without current asthma in 2015 (n=11 973) | Participants with current asthma in 2015 (n=372) | P value* | |
| Age, years, mean±SD | 69.8 (±3.5) | 69.8 (±3.5) | 69.8 (±3.5) | 0.93 |
| Sex, n (%) | ||||
| Female | 3 238 (26) | 3 116 (26) | 122 (33) | <0.01 |
| Marital status, n (%) | ||||
| Living alone | 2 186 (18) | 2 114 (18) | 72 (20) | 0.42 |
| Education, n (%) | ||||
| <High school | 2 412 (20) | 2 344 (20) | 68 (19) | 0.85 |
| High school | 7 156 (59) | 6 940 (59) | 216 (60) | |
| University and other | 2 564 (21) | 2 485 (21) | 79 (22) | |
| Body mass index (BMI), kg/m², mean±SD | 26.1±3.9 | 26.1±3.8 | 26.9±4.9 | <0.01 |
| Obese (BMI | 1 702 (14) | 1 616 (14) | 86 (23) | <0.001 |
| Current tobacco consumption, n (%) | ||||
| Non-smoker | 4 617 (44) | 4 475 (44) | 142 (46) | 0.84 |
| Current smoker | 778 (7) | 755 (7) | 23 (7) | |
| Former smoker | 5 113 (49) | 4 966 (49) | 147 (47) | |
| Frailty, n (%) | ||||
| Robust | 7 381 (60) | 7 198 (60) | 183 (49) | <0.001 |
| Pre-frail | 4 258 (34) | 4 116 (34) | 142 (38) | |
| Frail | 706 (6) | 659 (6) | 47 (13) | |
| Asthma, n (%) | ||||
| Current asthma in 2015 | 372 (3) | – | – | |
| Current asthma in 2002 | 1 456 (18) | 1 241 | 215 | |
| Constant reports | 103 (1.6) | 0 | 103 | |
| At least one | 1 165 (9) | 793 | 372 | |
| Confirmed by drug database | 281 (2.3) | 0 | 281 | |
| Sensibility | 154 (1.3) | 0 | 154 | |
| Mood, n (%) | ||||
| Depressed, stressed or anxious | 2 400 (19) | 2 293 (19) | 107 (29) | <0.001 |
| Other chronic diseases, N (%) | ||||
| Heart diseases | 853 (7) | 832 (7) | 21 (6) | 0.35 |
| Diabetes | 1 385 (11) | 1 329 (11) | 56 (15) | 0.02 |
| Joint pain | 5 305 (43) | 5 113 (43) | 192 (52) | <0.001 |
| Cancer | 1 530 (13) | 1 477 (13) | 53 (15) | 0.36 |
Sensibility definition: participants who constantly reported current asthma, or only once, in 2015, were considered as having current asthma; otherwise they were considered as not having current asthma.
*P value of t-test for continuous variables and χ2 test for categorical variables.
Figure 1Prevalence of frailty and pre-frailty among non-asthmatics (NA) and asthmatics (A) according to asthma definition legend. 1, current asthma in 2015 (A: n=372; NA: n=11 973); 2, current asthma symptoms in 2002 (A: n=1 456; NA: n=6 560); 3, constant current asthma reports (A: n=103; NA: n=6 206); 4, at least one asthma report (A: n=1 165; NA: n=11 180).
Associations between current asthma and pre-frailty/frailty
| Asthma definition | N | OR of pre-frailty | N | OR of frailty | |
| Current asthma in 2015 | Crude | 11 639 | 1.36 (1.09 to 1.70) | 8 087 | 2.81 (2.02 to 3.90) |
| M2 | 9 406 | 1.33 (1.03 to 1.72) | 6 561 | 2.47 (1.66 to 3.68) | |
| M3 | 9 303 | 1.26 (0.97 to 1.64) | 6 493 | 2.19 (1.44 to 3.34) | |
| Current asthma in 2002 | Crude | 7 552 | 1.74 (1.54 to 1.96) | 5 262 | 3.21 (2.61 to 3.95) |
| M2 | 6 204 | 1.62 (1.41 to 1.86) | 4 335 | 2.81 (2.20 to 3.59) | |
| M3 | 6 139 | 1.46 (1.26 to 1.68) | 4 293 | 2.24 (1.73 to 2.90) | |
| Constant report of current asthma between 1990 and 2015 | Crude | 6 018 | 1.56 (1.02 to 2.39) | 4 239 | 4.73 (2.65 to 8.43) |
| M2 | 4 971 | 1.55 (0.94 to 2.55) | 3 511 | 3.98 (1.92 to 8.25) | |
| M3 | 4 924 | 1.47 (0.89 to 2.44) | 3 481 | 3.67 (1.70 to 7.93) | |
| At least one report between 1990 and 2005 | Crude | 11 639 | 1.26 (1.10 to 1.43) | 8 087 | 2.19 (1.77 to 2.72) |
| M2 | 9 406 | 1.17 (1.01 to 1.36) | 6 561 | 1.78 (1.37 to 2.31) | |
| M3 | 9 303 | 1.09 (0.93 to 1.27) | 6 493 | 1.50 (1.15 to 1.98) | |
| Confirmed by drugs database | Crude | 11 558 | 1.32 (1.02 to 1.71) | 8 033 | 2.91 (2.01 to 4.22) |
| M2 | 9 343 | 1.26 (0.94 to 1.70) | 6 520 | 2.45 (1.56 to 3.85) | |
| M3 | 9 240 | 1.15 (0.85 to 1.55) | 6 452 | 2.00 (1.24 to 3.22) | |
| Sensibility | Crude | 11 639 | 1.30 (0.92 to 1.84) | 8 087 | 2.95 (1.81 to 4.81) |
| M2 | 9 406 | 1.37 (0.92 to 2.04) | 6 561 | 2.54 (1.38 to 4.67) | |
| M3 | 9 303 | 1.31 (0.87 to 1.97) | 6 493 | 2.37 (1.24 to 4.51) |
Results are expressed as OR (95% CI).
Model 2 (M2): adjusted for sex, age (continuous), body mass index (continuous), education, marital status, tobacco consumption.
Model 3 (M3): further adjustment on diabetes, joint pain, cancer, cardiac diseases and mental status.
Sensibility: participants who constantly reported current asthma, or only once, in 2015, were considered as having current asthma; otherwise they were considered as not having current asthma.